RT Journal Article
SR Electronic
T1 Is your patient at risk for NAFLD?
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 719
OP 727
DO 10.3949/ccjm.89a.22005
VO 89
IS 12
A1 Persons, Patress Ann
A1 Bersoux, Sophie
A1 Whited, Mary Helen
YR 2022
UL http://www.ccjm.org/content/89/12/719.abstract
AB Nonalcoholic fatty liver disease (NAFLD) affects approximately 37% of US adults. The progression from nonalcoholic fatty liver with no inflammation to steatohepatitis with inflammation and progressive fibrosis is associated with substantial morbidity and mortality. The epidemic of NAFLD requires that primary care providers recognize at-risk patients and screen them. The authors review identifying individuals at risk, treatment options founded on lifestyle modification, and when to consider referring patients to a hepatologist.